Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy.
Inomata M, Minatoyama S, Takata N, Hayashi K, Hirai T, Seto Z, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Miwa T, Matsuyama K, Hayashi R, Matsui S, Tobe K.
Inomata M, et al. Among authors: imanishi s.
Anticancer Res. 2024 Mar;44(3):1241-1245. doi: 10.21873/anticanres.16920.
Anticancer Res. 2024.
PMID: 38423671